ALISO VIEJO, Calif., Dec. 9, 2010 /PRNewswire/ — Ambry
Genetics, a global leader in genomic services to the healthcare and
life sciences industries, announced today that it has officially
launched their Illumina HiSeq 2000 Next Generation Sequencing
Services. Ambry Genetics has been an early adapter of Illumina
sequencing systems since 2007 and has extensive experience as a
Certified Service Provider.
(Logo: http://photos.prnewswire.com/prnh/20090428/LA06744LOGO)
“We’ve continued to invest and develop our sequencing operations
to become Illumina experts,” said Ardy Arianpour, Vice President of
Business Development at Ambry Genetics. “All of our customers
are excited about the Illumina HiSeq because it expands our whole
genome and exome sequencing services to the next level and gives
them the opportunity to reduce their costs while providing more
data. If Illumina is your preferred platform then we want to
be your preferred sequencing provider.”
Ambry Genetics has been at the forefront of applying new
sequencing technologies that best meet our clients’ needs. A
team of scientists routinely process libraries for all available
applications ranging from small RNAs to whole genome DNA
sequencing. Having sequenced thousands of samples involving a
wide range of species including human, mouse, bacteria, viruses,
and plants, Ambry is known for its reputation for delivering
quality data and service as well as the flexibility in customizing
projects to meet the specific needs of researchers. Ambry
Genetics will get your projects done right.
About Ambry Genetics -Ambry Genetics is a CAP-accredited
and CLIA-certified commercial clinical laboratory headquartered in
Aliso Viejo, California. Since the company’s inception in 2000, it
has become a leader in providing genetic services focused on
clinical diagnostics and genomic services. Amb
‘/>”/>
SOURCE